1 GLP-1RAs can be added to any combination of other therapies (except DPP-4 inhibitors), including insulin and SGLT-2 inhibitors, although this is not subsidised by the PBS
Not for therapeutic, diagnostic, or cosmetic purposes
Conversely, indicators of responsible positioning include: honest acknowledgment that mechanisms differ from pharmaceutical drugs, realistic expectation-setting about gradual metabolic support rather than dramatic transformation, transparent disclosure of all strains and doses, quality manufacturing claims (GMP certification, third-party testing), and guarantee periods aligning with research assessment timelines
L-carnitine for acute valproic acid overdose: A systematic review of published cases
Indirect antioxidants , such as melatonin , which boost the skins ability to repair oxidative damage